Concepedia

Kirstine Brown‐Frandsen

KB

5

Publications

8.8K

Citations

5

H-Index

2016

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

University of North Carolina at Chapel Hill

Novo Nordisk (Denmark)

Imperial College London

Lunenfeld-Tanenbaum Research Institute

Kirstine Brown‐Frandsen is an author at The University of Texas Southwestern Medical Center.

Publications per year

2016–2023

5

Publications

5

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7K citations · Full text

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

Steven P. Marso, Darren K. McGuire, Bernard Zinman et al. · New England Journal of Medicine · 2017 · 556 citations · Full text

Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of <scp>SOUL</scp> , a randomized trial

Darren K. McGuire, Rodica Pop‐Busui, John Deanfield et al. · Diabetes Obesity and Metabolism · 2023 · 114 citations · Full text

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

Kirstine Brown‐Frandsen, Scott S. Emerson, Darren K. McGuire et al. · Diabetes Obesity and Metabolism · 2019 · 16 citations · Full text

Rows per page

1–5 of 5